©2024 Stanford Medicine
Investigating Two rTMS Strategies to Treat Cannabis Use Disorder
Recruiting
I'm InterestedTrial ID: NCT05720312
Purpose
In this trial we will work with a group of participants who are having problems related to
marijuana use (they have Cannabis Use Disorder) and who want to reduce the amount of
marijuana they use or quit using marijuana completely. We are testing to see if a treatment
called repetitive transcranial magnetic stimulation (rTMS) can help them achieve that goal
when combined with a brief three-session counseling therapy. Participants will receive rTMS
to one of two different parts of the brain (the dorsolateral prefrontal cortex--the DLPFC or
the ventromedial prefrontal cortex--the vmPFC) to see if applying rTMS to one brain area is
more helpful than the other brain area.
Official Title
A Preliminary Investigation of Two Repetitive Transcranial Magnetic Stimulation (rTMS) Strategies to Treat Cannabis Use Disorder
Stanford Investigator(s)
Gregory Lee Sahlem
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
Eligibility
Inclusion Criteria:
1. Participants must be able to provide informed consent and function at an intellectual
level sufficient to allow accurate completion of all assessment instruments.
2. Participants must be between the ages of 18 and 60.
3. Participants must meet DSM-5 criteria for at least moderate Cannabis Use Disorder,
with use of at least 20 out of the last 28 days.
4. Participants must express a desire to reduce cannabis use or quit.
5. Participants must have a positive UDS for cannabis during their enrollment visit
(confirming they are regular users).
6. The investigative team must believe each participant is a good study-candidate.
Exclusion Criteria:
1. Participants must not be pregnant or breastfeeding.
2. Participants must not meet moderate or severe use disorder of any other substance with
the exception of tobacco/nicotine.
3. Participants must not be on any medications that have central nervous system effects
that have changed in the past 4-weeks.
4. Participants must not have a history of/or current psychotic disorder or bipolar
disorder.
5. Participants must not have any other Axis I condition requiring current treatment.
6. Participants must not have a history of Dementia or other cognitive impairment.
7. Participants must not have active suicidal ideation, or a suicide attempt within the
past 180 days.
8. Participants must not have any contraindications to receiving rTMS or MRI (e.g. metal
implanted above the head, history of seizure, any known brain lesion).
9. Participants must not have any unstable general medical conditions.
Intervention(s):
device: Repetitive Transcranial Magnetic Stimulation (rTMS)
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Study Team
650-374-0907